Loss of control of asthma following inhaled corticosteroid withdrawal is associated with increased sputum interleukin-8 and neutrophils

Chest

Volumn 132, Issue 1, 2007, Pages 98-105

  Maneechotesuwan, Kittipong ^c   Essilfie Quaye, Sarah ^a   Kharitonov, Sergei A ^c   Adcock, Ian M ^c   Barnes, Peter J ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Airways Disease Section   (United Kingdom)

^c NONE

Author keywords

Asthma; Exacerbation; Interleukin 8; Neutrophil

Indexed keywords

BUDESONIDE; CORTICOSTEROID; INTERLEUKIN 8; PLACEBO; SALBUTAMOL; TERBUTALINE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG WITHDRAWAL; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; NEUTROPHIL COUNT; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPUTUM ANALYSIS;

EID: 34447509985     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-2982     Document Type: Article

References (29)

1. Brightling CE, Ward R, Woltmann G, et al. Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma. Am J Respir Crit Care Med 2000; 162:878-882
2. Gibson PG, Norzila MZ, Fakes K, et al. Pattern of airway inflammation and its determinants in children with acute severe asthma. Pediatr Pulmonol 1999; 28:261-270
3. Fahy JV, Kim KW, Liu J, et al. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995: 95:843-852
4. Lamblin C, Gosset P, Tillie-Leblond I, et al. Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am J Respir Crit Care Med 1998; 157:394-402
5. Sur S, Crotty TB, Kephart GM, et al. Sudden onset fatal asthma: a distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa. Am Rev Respir Dis 1993; 148:713-719
6. Busse WW, Lemanske RF. Asthma. N Engl J Med 2001; 344:350-362
7. Barnes PJ. Cytokine-directed therapies for the treatment of chronic airway diseases. Cytokine Growth Factor Rev 2003; 14:511-522
8. Kim CK, Kim JT, Kang H, et al. Sputum eosinophilia in cough-variant asthma as a predictor of the subsequent development of classic asthma. Clin Exp Allergy 2003; 33:1409-1414
9. Johnston SL, Papi A, Monick MM, et al. Rhinoviruses induce interleukin-8 mRNA and protein production in human monocytes. J Infect Dis 1997; 175:323-329
10. Kanazawa H, Kurihara N, Otsuka T, et al. Clinical significance of serum concentration of interleukin 8 in patients with bronchial asthma or chronic pulmonary emphysema. Respiration 1996; 63:236-240
11. Gilroy DW, Lawrence T, Perretti M, et al. Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 2004; 3:401-416
12. in't Veen JC, Smits HH, Hiemstra PS, et al. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. Am J Respir Crit Care Med 1999; 160:93-99
13. Sterk PJ, Fabbri LM, Quanjer PH, et al. Airway responsiveness: standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal; Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16:53-83
14. Pizzichini MM, Pizzichini E, Efthimiadis A, et al. Asthma and natural colds: inflammatory indices in induced sputum; a feasibility study. Am J Respir Crit Care Med 1998; 158:1178-1184
15. Norzila MZ, Fakes K, Henry RL, et al. Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma. Am J Respir Crit Care Med 2000; 161:769-774
16. Ordonez CL, Shaughnessy TE, Matthay MA, et al. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: clinical and biologic significance. Am J Respir Crit Care Med 2000; 161:1185-1190
17. Pizzichini MM, Pizzichini E, Clelland L, et al. Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment. Am J Respir Crit Care Med 1997; 155:1501-1508
18. Basyigit I, Yildiz F, Ozkara SK, et al. Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients. Mediat Inflamm 2004; 13:285-291
19. Gibson PG, Wong BJ, Hepperle MJ, et al. A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid. Clin Exp Allergy 1992; 22:525-532
20. Jatakanon A, Lim S, Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 2000; 161:64-72
21. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360:1715-1721
22. Jayaram L, Pizzichini MM, Cook RJ, et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 2006; 27:483-494
23. Chlumsky J, Striz I, Terl M, et al. Strategy aimed at reduction of sputum eosinophils decreases exacerbation rate in patients with asthma. J Int Med Res 2006; 34:129-139
24. Pizzichini MM, Pizzichini E, Clelland L, et al. Prednisone-dependent asthma: inflammatory indices in induced sputum. Eur Respir J 1999; 13:15-21
25. Veen JC, Smits HH, Ravensberg AJ, et al. Impaired perception of dyspnea in patients with severe asthma: relation to sputum eosinophils. Am J Respir Crit Care Med 1998; 158:1134-1141
26. Barnes PJ, Adcock IM. How do corticosteroids work in asthma? Ann Intern Med 2003; 139:359-370
27. Maneechotesuwan K, Essilfie-Quaye S, Meah S, et al. Formoterol attenuates neutrophilic airway inflammation in asthma. Chest 2005; 128:1936-1942
28. Kurashima K, Mukaida N, Fujimura M, et al. Increase of chemokine levels in sputum precedes exacerbation of acute asthma attacks. J Leukoc Biol 1996; 59:313-316
29. Meagher LC, Cousin JM, Seckl JR, et al. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996; 156:4422-4428